KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
This Quarter Return
+4.4%
1 Year Return
+14.33%
3 Year Return
+109.21%
5 Year Return
+340.79%
10 Year Return
–
AUM
$87.8M
AUM Growth
+$87.8M
(-29%)
Cap. Flow
-$37.7M
Cap. Flow
% of AUM
-42.99%
Top 10 Holdings %
Top 10 Hldgs %
58.31%
Holding
59
New
–
Increased
–
Reduced
40
Closed
12
Top Buys
No buys this quarter
Top Sells
| 1 |
IDTI
Integrated Device Technology I
IDTI
|
$5.42M |
| 2 |
CLDR
Cloudera, Inc.
CLDR
|
$4.32M |
| 3 |
Twilio
TWLO
|
$2.27M |
| 4 |
NeoGenomics
NEO
|
$1.51M |
| 5 |
CY
Cypress Semiconductor
CY
|
$1.5M |
Sector Composition
| 1 | Healthcare | 42.56% |
| 2 | Technology | 39.72% |
| 3 | Financials | 2.7% |
| 4 | Consumer Discretionary | 2.19% |
| 5 | Industrials | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $7.18M | 8.18% | 327,438 -68,889 | -17% | -$1.51M |
|
|
2
Twilio
TWLO
$16.2B
| $6.69M | 7.62% | 49,044 -16,635 | -25% | -$2.27M |
|
3
Vericel Corp
VCEL
$1.83B
| $5.99M | 6.82% | 317,079 -73,995 | -19% | -$1.4M |
|
|
CY
4
DELISTED
Cypress Semiconductor
CY
| $5.53M | 6.3% | 248,494 -67,312 | -21% | -$1.5M |
|
5
Upland Software
UPLD
$81.4M
| $5.04M | 5.74% | 110,613 -27,445 | -20% | -$1.25M |
|
6
CyberArk
CYBR
$22.8B
| $4.78M | 5.44% | 37,383 -10,161 | -21% | -$1.3M |
|
7
Omnicell
OMCL
$1.5B
| $4.17M | 4.75% | 48,428 -12,638 | -21% | -$1.09M |
|
8
AtriCure
ATRC
$1.84B
| $4.02M | 4.58% | 134,696 -37,273 | -22% | -$1.11M |
|
|
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.9M | 4.44% | 162,142 -40,385 | -20% | -$972K |
|
10
Insulet
PODD
$23.9B
| $3.9M | 4.44% | 32,629 -3,956 | -11% | -$472K |
|
11
FIVE9
FIVN
$2.08B
| $3.62M | 4.13% | 70,614 -18,212 | -21% | -$934K |
|
12
MaxLinear
MXL
$1.37B
| $3.4M | 3.88% | 145,212 -36,544 | -20% | -$857K |
|
|
SRGA
13
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $3.07M | 3.5% | 722,397 -165,298 | -19% | -$702K |
|
|
XENT
14
DELISTED
Intersect ENT, Inc
XENT
| $3.03M | 3.45% | 132,924 -28,184 | -17% | -$641K |
|
15
Supernus Pharmaceuticals
SUPN
$2.53B
| $2.56M | 2.92% | 77,392 -22,583 | -23% | -$747K |
|
|
FNSR
16
DELISTED
Finisar Corp
FNSR
| $2.36M | 2.69% | 103,348 -31,957 | -24% | -$731K |
|
17
Commault Systems
CVLT
$8.3B
| $2.09M | 2.38% | 42,180 -13,248 | -24% | -$657K |
|
18
Ligand Pharmaceuticals
LGND
$3.15B
| $1.63M | 1.85% | 14,263 -4,928 | -26% | -$562K |
|
19
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.3M | 1.49% | 4,450 | – | – |
|
20
Apple
AAPL
$3.45T
| $889K | 1.01% | 4,494 -2,842 | -39% | -$562K |
|
21
Marriott International Class A Common Stock
MAR
$72.7B
| $740K | 0.84% | 5,276 -3,218 | -38% | -$451K |
|
22
Aflac
AFL
$57.2B
| $701K | 0.8% | 12,798 -7,529 | -37% | -$412K |
|
23
Procter & Gamble
PG
$368B
| $643K | 0.73% | 5,866 -3,576 | -38% | -$392K |
|
24
Invesco QQQ Trust
QQQ
$364B
| $640K | 0.73% | 3,425 | – | – |
|
25
JPMorgan Chase
JPM
$829B
| $612K | 0.7% | 5,477 -3,450 | -39% | -$386K |
|